- Nicolas Jaé: From the Institute for Cardiovascular Regeneration (N.J., S.D.), Goethe University Frankfurt, Germany.
- Stefanie Dimmeler: From the Institute for Cardiovascular Regeneration (N.J., S.D.), Goethe University Frankfurt, Germany.
The advent of deep sequencing technologies led to the identification of a considerable amount of noncoding RNA transcripts, which are increasingly recognized for their functions in controlling cardiovascular diseases. MicroRNAs have already been studied for a decade, leading to the identification of several vasculoprotective and detrimental species, which might be considered for therapeutic targeting. Other noncoding RNAs such as circular RNAs, YRNAs, or long noncoding RNAs are currently gaining increasing attention, and first studies provide insights into their functions as mediators or antagonists of vascular diseases in vivo. The present review article will provide an overview of the different types of noncoding RNAs controlling the vasculature and focus on the developing field of long noncoding RNAs.